Cargando…
Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy
Triple-negative breast cancer (TNBC) typically has a worse outcome than other breast cancer subtypes, in part owing to a lack of approved therapeutic targets or prognostic markers. We have previously described an oncogenic pathway in basal-like TNBC cells, initiated by insulin-like growth factor bin...
Autores principales: | Julovi, Sohel M., Martin, Janet L., Baxter, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874320/ https://www.ncbi.nlm.nih.gov/pubmed/29623068 http://dx.doi.org/10.3389/fendo.2018.00120 |
Ejemplares similares
-
Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast Cancer
por: Marzec, Kamila A., et al.
Publicado: (2015) -
Insulin-Like Growth Factor Binding Proteins in Autoimmune Diseases
por: Ding, Huihua, et al.
Publicado: (2018) -
Insulin-Like Growth Factor-Binding Proteins of Teleost Fishes
por: Garcia de la Serrana, Daniel, et al.
Publicado: (2018) -
Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade
por: Martin, Janet L., et al.
Publicado: (2017) -
Insulin-Like Growth Factor Binding Proteins: A Structural Perspective
por: Forbes, Briony E., et al.
Publicado: (2012)